Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. - Wikidata - wikimedia - TriplyDB

Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis.

Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis.

http://www.wikidata.org/entity/Q33805271

about

Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women The Diagnosis and Treatment of Autoimmune Encephalitis Strategies for fertility preservation in young patients with cancer: a comprehensive approach 'An ounce of prevention is worth a pound of cure': the case for and against GnRH-agonist for fertility preservation.Fertility and pregnancy in rheumatoid arthritis and systemic lupus erythematosus.Emerging gonadotropin-releasing hormone agonists.Clinical guide to fertility preservation in hematopoietic cell transplant recipients Assessment of fertility protection and ovarian reserve with GnRH antagonist in rats undergoing chemotherapy with cyclophosphamide Fertility preservation and GnRHa for chemotherapy: debate.Gonadotropin-Releasing Hormone Analog Cotreatment for the Preservation of Ovarian Function during Gonadotoxic Chemotherapy for Breast Cancer: A Meta-Analysis.Assessment of ovarian function after preparative chemotherapy and total body radiation for adoptive cell therapy Fertility preservation in women--a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT.Protective effect of gonadotropin-releasing hormone analog on the ovarian reserve in rats receiving cyclophosphamide treatment.NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks.Paraneoplastic disorders Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function.Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's).Fertility preservation in reproductive-age women facing gonadotoxic treatments.Fertility considerations in young women with hematological malignancies.Adjunctive GnRH-a treatment attenuates depletion of ovarian reserve associated with cyclophosphamide therapy in premenopausal SLE patients.Protecting Effects of Gonadotropin-Releasing Hormone Agonist on Chemotherapy-Induced Ovarian Damage in Premenopausal Breast Cancer Patients: A Systematic Review and Meta-Analysis.Human Umbilical Cord Mesenchymal Stem Cells Therapy in Cyclophosphamide-Induced Premature Ovarian Failure Rat Model.Novel evidence that pituitary gonadotropins directly stimulate human leukemic cells-studies of myeloid cell lines and primary patient AML and CML cells.Granulocyte colony-stimulating factor with or without stem cell factor extends time to premature ovarian insufficiency in female mice treated with alkylating chemotherapy.Ovarian Damage During chemotherapy in Autoimmune Diseases: Broad Health Implications beyond Fertility.Oncofertility in Canada: gonadal protection and fertility-sparing strategies.Fertility preservation in gynecological cancers.Primary ovarian insufficiency: an update.Ovarian function after hematopoietic cell transplantation: a descriptive study following the use of GnRH agonists for myeloablative conditioning and observation only for reduced-intensity conditioning Fertility-preserving treatment options in patients with malignant hematological diseases.Fertility conservation in breast cancer patients.Fertility preservation in women with cancer: importance of a multidisciplinary approach.Fertility sparing in cancer patients.Fertility preservation methods in young women with systemic lupus erythematosus prior to cytotoxic therapy: experiences from the FertiPROTEKT network.Pregnancy and renal outcomes in lupus nephritis: an update and guide to management.An update on primary ovarian insufficiency.Female fertility loss and preservation: threats and opportunities.Preserving fertility when choosing chemotherapy regimens - the role of gonadotropin-releasing hormone agonists.Combining randomized and non-randomized evidence in clinical research: a review of methods and applications.

P2860

Q24235150-27F44A4E-AC11-46DA-B54F-ED2664E950A9 Q26769676-A401AC5E-07A7-4A3B-8C40-A1714FCCEA37 Q27002719-0D99241D-3968-46DE-9A0E-CB4536894E06 Q30360464-656D9447-829E-47AB-8F6F-3B3E603F4FE7 Q33654712-ED5DA6D3-8C2C-4F68-A25F-C74ACD981E1E Q33796122-45174D21-1EE7-42C8-9348-785D47EB63D0 Q33809651-3EED279B-D423-4EDB-B07E-4D16BBD94E3D Q33912179-1A48CD5E-A6F9-4A99-A889-351808C48A05 Q34090263-F166B6D9-EE28-4B5A-8991-8C422A366FC0 Q34785329-67F21A9F-9E23-45F4-9361-AE675D68F76D Q34954883-E362FA1B-2F6B-4295-A75D-A23044A34863 Q35097386-7025FF81-D68D-46CD-A30C-650417A86656 Q35223404-62930714-E2A8-46F6-8B69-1ED2CBF20F4F Q35563274-D0FFC6DD-2EED-4EC9-887A-846039833A09 Q35646721-8D0C18F8-6D9D-4956-8288-675402AEF4BA Q35776206-3C5C033E-8770-456E-A4F2-50666E1A66F7 Q35776251-BD8577FA-B359-4665-8372-58E5EAC19A38 Q35835278-0397F6FC-025A-46B6-AC4A-7EBE4FB4DD03 Q35934317-73A59394-30BE-40B9-95EF-B6D700A62DA4 Q36016181-44703FDB-39D4-47AA-BE70-A0FDC738BBE1 Q36094947-7A2EDE4D-0B10-4929-8E2B-F6D323D7F8A4 Q36404774-33F76E80-3722-4758-B35E-6C02B12023F8 Q36707192-7FF2F98D-62BE-428B-A297-6D24C5F82E2C Q36772015-61203A3C-8629-440C-BB32-2DFAB94FB261 Q36901831-63A8160F-F756-4E8C-BC7B-EEB0284E3C3C Q37105605-248E284B-4DE4-4CA8-AF91-E417A6CDBC57 Q37364626-22DD8215-033B-4084-B69D-180A4EE6A288 Q37463014-9E8B3DB9-9060-4DE5-AED9-833CE8CB0D07 Q37603106-77FEE834-E952-44A7-9418-97AA29DE0093 Q37633480-F4046417-E919-4946-BC58-7788B4392E98 Q37702800-0C646461-BE96-404F-85E9-79AFAAE80C72 Q37853557-566B56F5-1527-440B-A6CE-BD2D1CE1DB08 Q37924284-46685281-C136-4F17-83CD-765AA0FA8C83 Q37932564-9D37862A-3440-43E5-998C-C8D72E0CD583 Q37995966-3C2E540B-EF5F-4295-BF63-EB6E9A7D4FB5 Q38033398-EF1F5DB9-6EC3-4EBE-A57C-6E1549B2FA77 Q38038997-DAEB3BAE-8047-4420-B2D8-1D91354388EF Q38057986-A1AA7DA3-7400-45CD-9951-A9B2E7282ABD Q38397291-E07F33CF-99C2-4ACC-9E0C-DD05DBC45360 Q38512940-63706484-3F07-48DB-9C96-34B8ECBDB1B3

P2860

Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis.

http://www.wikidata.org/entity/Q33805271

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis.

@ast

Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis.

@en

type

label

Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis.

@ast

Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis.

@en

prefLabel

Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis.

@ast

Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis.

@en

P1433

Q33805271-F2CFB021-FD0B-4EFD-87CB-0C2B66833F8A

P1476

Q33805271-5A5B4A3C-5333-4AFD-A3C3-2C18CB36D669

P2093

Q33805271-70861BEF-77F1-4D7E-9A8D-D3E51A508F67

Q33805271-80AAADE1-1122-4637-9E50-E1F45902F246

Q33805271-B41B121F-0355-41BE-9CEB-86A591BE37E8

Q33805271-BA147B16-0C46-473C-B233-11D2276D55CD

Q33805271-BBE39542-62A5-44B6-9120-7E311A725736

Q33805271-E769946E-4BBF-4074-AA0D-CECBF7B9ADAA

Q33805271-ED5D7095-E287-4819-86AE-69C6141D0F41

P2860

Q33805271-0D24F085-E2E9-464C-BD4A-5D5F950ECE2B

Q33805271-11056FC2-7BD3-4F44-9E48-BCDEB4DA7816

Q33805271-14D96FF0-3647-48BE-A7AF-B47F943DE7F7

Q33805271-1577B13B-9C2F-4ED0-B09B-9FAC572A7C0D

Q33805271-178477A8-8A16-44F4-95B8-0F52A081554B

Q33805271-1AB0C904-7D21-48DB-8573-C36B6D876333

Q33805271-1B4D8863-E9FD-4717-A5D8-93D5DC3B947E

Q33805271-236441EE-164E-4D02-A048-99AE9C2E5754

Q33805271-275B9913-775D-4313-8786-04DC66D9E237

Q33805271-285F05A4-6F7A-44D0-BC13-FB2F15D2435C

P304

Q33805271-C7BDAEF6-B227-4D6F-A642-E9FF0D5E03BC

P31

Q33805271-41d592d6-4685-4021-95ad-4ac3f8958287

Q33805271-70C6CE8E-D178-4AA7-A506-ED12DB7BC36F

P356

Q33805271-0CDD7502-5BB4-42B0-9F9D-8FDDE82F55A7

P433

Q33805271-A737E3BD-A39E-4046-936D-31E09D4B31D6

P478

Q33805271-B02A8F62-1D78-40A3-9630-29A7397DB1B5

P577

Q33805271-1E1A2877-359D-41FC-8164-B75CC060A484

P5875

Q33805271-B21A27DD-880B-4EEC-A601-7D76A6897B7A

P698

Q33805271-AB8E74D7-1980-4329-891C-1C26D89A8AC6

P921

Q33805271-38F7B4EA-39AC-4392-9254-E52E6BD9828C

P932

Q33805271-9221B34F-8C1E-4970-A8FC-24BA005E30D7

P356

P1433

Journal of Women's Health

P1476

Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis.

@en

P2093

Carey K Anders

http://www.w3.org/2001/XMLSchema#string

Cynthia J Coffman

http://www.w3.org/2001/XMLSchema#string

Lori A Bastian

http://www.w3.org/2001/XMLSchema#string

Megan E B Clowse

http://www.w3.org/2001/XMLSchema#string

Millie A Behera

http://www.w3.org/2001/XMLSchema#string

Phyllis C Leppert

http://www.w3.org/2001/XMLSchema#string

Susannah Copland

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

Tissue-engineered follicles produce live, fertile offspring

Luteinizing hormone-releasing hormone analogue: leuprorelin acetate for the prevention of menstrual bleeding in premenopausal women undergoing stem cell transplantation.

Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide.

Premature ovarian failure: etiology and prospects.

Clinical pharmacokinetics of depot leuprorelin.

Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients.

Sequential comparisons of one-month and three-month depot leuprolide regimens in central precocious puberty.

Failure to preserve fertility in patients with Hodgkin's disease.

GnRH antagonists in the treatment of gynecological and breast cancers.

P304

311-319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/JWH.2008.0857

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24196218

http://www.w3.org/2001/XMLSchema#string

P698

19281314

http://www.w3.org/2001/XMLSchema#string

P921

P932

2858300

http://www.w3.org/2001/XMLSchema#string